Systemic markers of inflammation in preterm very low birth weight infants depending on the method of secondary non-invasive respiratory support
Development of inflammatory reactions (biotrauma) is the primary mechanism of lung injury during mechanical ventilation. Cytokines play a key role in this process. This open randomized study looked at the influence of different methods of respiratory support on IL-6 and IL-8 serum levels in very preterm infants. The study included 47 very preterm infants (gestation age ≤ 32 weeks) with respiratory distress syndrome (RDS) who were treated with mechanical ventilation (MV). Within the first three days of life, before extubation infants were randomized into two groups: non-invasive ventilation (NV) (n = 19) and continuous positive airway pressure (СРАР) (n = 18). The third group included 10 infants ventilated longer than three days (comparison group).The levels of interleukins in blood serum were measured by ELISA on the 3rdand on the 14th day of life. Mortality, incidences of bronchopulmonary dysplasia (BPD), as well as duration of MV, noninvasive respiratory support (NRS), and oxygen therapy were compared in the groups. No differences were observed between the NV and CPAP groups in the duration of MV and NRS. Infants from the comparison group needed longer MV with higher ventilation settings. There were no statistically significant differences between the levels of IL-6 and IL-8 in the groups on the 3rdand on the 14th day of life. However, statistically significant reduction of IL-6 concentrations was observed in the NV group on the 14thday of life compared to the initial ones (Р < 0.01). Longer duration of MV (rS = 0.3; P < 0.05), death (rS = 0.3; P < 0.05), BPD or death (rS = 0.34; P < 0.05) were associated with higher IL-6 levels on the 3rdday of life. Longer duration of NRS support (rS = 0.5; P < 0.05), longer neonatal intensive care unit stay (rS = 0.44; P < 0.05), BPD or death (rS = 0.33; P < 0.05), and moderate BPD (rS = 0.35; P < 0.05) were associated with higher IL-6 levels on the 14thday of life. Levels of IL-8 assessed on the third and 14th days of life did not correlate with duration of respiratory support, incidence of BPD or mortality. Non-invasive ventilation is associated with statistically significant reduction of serum IL-6 levels in preterm infants as opposed to CPAP. Moderate BPD was associated with higher IL-6 levels on the 14th day of life. Therefore non-invasive ventilation may be consider a safer respiratory support method in comparison with CPAP.
Ambalavanan N., Carlo W. A., D'Angio C. T. et al. Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants // Pediatrics. – 2009. – Vol. 123. – P. 1132–1141.
Anderson C., Sweet D. Non-Invasive Respiratory Support in Preterm Babies [Електронний ресурс] / Режим доступу: http://www.cureandcareportal.com.
Attar M. A., Donn S. M. Mechanisms of ventilator-induced lung injury in premature infants // Semin Neonatol. – 2002. – Vol. 7. – P. 353–360.
Carvalho C. G., Silveira R.de C., Neto E. C. et al. Plasma cytokine levels fall in preterm newborn infants on nasal CPAP with early respiratory distress // PLoS One. – 2015. – Vol. 23, N 10. – е0120486.
Gabay C. Interleukin-6 and chronic inflammation // Arthritis Res Ther. – 2006. – Vol. 8. – S. 3–7.
Halbertsma F. J. J., Vaneker M., Scheffer G. J. et al. Cytokines and biotrauma in ventilator-induced lung injury: a critical review of the literature // The Netherlands J. of Med. – 2005. – Vol. 63, N 10. – P. 382–392.
Hofer N., Kothari R., Morris N. et al. The fetal inflammatory response syndrome is a risk factor for morbidity in preterm neonates // Am. J. Obstet. Gynecol. – 2013. – Vol. 209. – P. 542.e1–542.e11.
Hubmayr R. D. Ventilator induced lung injury without biotrauma? // J. Appl. Physiol. – 2005. – Vol. 99. – P. 384–385.
Jobe A. H., Bancalari E. Bronchopulmonary dysplasia // Am. J. Respir. Crit. Care Med. – 2001. – Vol. 163. – P. 1723–1729.
Jobe A. H., Kramer B. W., Moss T. J. et al. Decreased indicators of lung injury with continuous positive expiratory pressure in preterm lambs // Ped. Res. – 2002. – Vol. 52. – P. 387–392.
Jonsson B., Tullus K., Brauner A. et al. Early increase of TNFα and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants // Arch. Dis. Child. Fetal Neonatal Ed. – 1997. – Vol. 77. – P. 198–201.
Kallapur S. G., Jobe A. H. Contribution of inflammation to lung injury and development // Arch. Dis. Child. Fetal Neonatal Ed. – 2006. – Vol. 91. – P. 132–135.
Kugelman A. International perspectives: Nasal ventilation in preterm infants: An Israel perspective // NeoReviews. – 2009. – Vol. 10. – P. 157–165.
Lista G., Castoldi F., Fontana P. et al. Nasal continuous positive airway pressure (CPAP) versus bi-level nasal CPAP in preterm babies with respiratory distress syndrome: a randomised control trial // Arch. Dis. Child. Fetal Neonatal Ed. – 2010. – Vol. 95. – P. 85–89.
Pacora P., Chaiworapongsa T., Maymon E. et al. Funisitis and chronic vasculitis: the histological counterpart of the fetal inflammatory response syndrome // J. Matern. Fetal Med. – 2002. – Vol. 11. – P. 18–25.
Pietrzyk J. J., Kwinta P., Wollen E. J. et al. Gene expression profiling in preterm infants: new aspects of bronchopulmonary dysplasia development // PLoS One. – 2013. – Vol. 8. – е78585.
Richardson D. K. , Corcoran J. D., Escobar G. J., Lee S. K. SNAP-II and SNAPPE-II: simplified newborn illness severity and mortality risks cores // J. Pediatr. – 2001. – Vol. 138. – P. 92–100.
Speer C. P. Pulmonary inflammation and bronchopulmonary dysplasia // J. Perinatol. – 2006. – Vol. 26. – P. S57–S62.
Uhlig S., Ranieri M., Slutsky A. S. Biotrauma hypothesis of ventilator-induced lung injury // Am. J. Respiratory and Critical Care Med. – 2004. – Vol. 169. – P. 314–316.
Vento G., Capoluongo E., Matassa P. G. et al. Serum levels of seven cytokines in premature ventilated newborns: correlations with old and new forms of bronchopulmonary dysplasia // Intensive Care Med. – 2006. – Vol. 3. – P. 723–730.
Walsh M. C., Wilson-Costello D., Zadell A. et al. Safety, reliability, and validity of a physiologic definition of bronchopulmonary dysplasia // J. Perinatol. – 2003. – Vol. 23. – P. 451–456.
Wright C. J., Kirpalani H. Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies? // Pediatrics. – 2011. – Vol. 128. – P. 111–126.
Abstract views: 81 PDF Downloads: 57
This work is licensed under a Creative Commons Attribution 4.0 International License.